Title
PCSK9 inhibition in patients with heart transplantation: A case series
Publication Date
2019
Journal Title
J Clin Lipidol
Abstract
© 2019 National Lipid Association PCSK9 inhibitors are potent low-density lipoprotein cholesterol–lowering medications. There is a lack of data regarding safety and efficacy of PCSK9 inhibitors in cardiac transplant patients. In this case series, we provide data supporting the low-density lipoprotein–lowering efficacy and short-term safety of PCSK9 inhibitors in three cardiac transplant patients.
Document Type
Article
Status
Faculty
Facility
School of Medicine
Primary Department
Cardiology
PMID
DOI
10.1016/j.jacl.2019.06.010